| Project Title | Anti-epileptic Drugs and Angioedema |
| Date Posted | Monday, July 17, 2017 |
| Project ID | to16_cap_mpl1r_wp047_nsdp_v01 |
| Status | Complete |
| Deliverables | |
| Description | Modular program-based one-time assessment of incidence rates of angioedema among new users of oral levetiracetam and four other oral anti-epileptic drugs (AEDs). This query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2008 to December 31, 2014. Modular programs are adaptable standardized programs. Results were generated using the Cohort Identification and Analysis (CIDA) tool, version 2.0.8. This query was distributed in October 2015. This report includes data from 15 Data Partners. If you are using a web page screen reader and are unable to access this document, please contact the Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@sentinelsystem.org. |
| Medical Product | lacosamide lamotrigine levetiracetam oxcarbazepine phenytoin |
| Health Outcome | angioedema |
| Population / Cohort | All individuals |
| Time Period | January 1, 2008 - December 31, 2014 |
| Assessment Type | Exploratory Analyses |
| Study Type | Modular Program |
| Data Sources | Mini-Sentinel Distributed Database (MSDD) |
| FDA Center | CDER |
